Arcus Capital Partners, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.8%.

Quarter-by-quarter ownership
Arcus Capital Partners, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$45,000
+9.8%
25,0000.0%0.02%
+20.0%
Q2 2019$41,000
-8.9%
25,0000.0%0.02%
-11.8%
Q1 2019$45,00025,0000.02%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$42,747,00027.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 637,696$650,0000.13%
Integrated Advisors Network LLC 478,630$488,0000.10%
BARD ASSOCIATES INC 79,400$81,0000.06%
Kore Private Wealth LLC 202,366$206,0000.05%
HighTower Advisors, LLC 5,284,688$5,390,0000.04%
NEXPOINT ASSET MANAGEMENT, L.P. 158,520$162,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 509,200$519,0000.01%
Summit X, LLC 25,500$26,0000.01%
American Portfolios Advisors 111,687$113,9210.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders